abstract |
Novel combination therapies are described which comprise nitroxoline, an analogue thereof, or a pharmaceutically acceptable salt thereof, and at least one additional anti-cancer chemotherapeutic or immunotherapeutic agent. Related kits, pharmaceutical compositions and methods of production are also described. |